POAS
Phaos Technology Holdings (Caym
Price Chart
Latest Quote
$0.22
| Previous Close | $0.22 |
| Open | $0.21 |
| Day High | $0.23 |
| Day Low | $0.20 |
| Volume | 88,096 |
Stock Information
| Shares Outstanding | 16.45M |
| Total Debt | $3.03M |
| Cash Equivalents | $83K |
| Revenue | $149K |
| Net Income | $-3.58M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $6.84M |
| EPS (TTM) | $-0.27 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $9.38M |
| Sales | $149K |
| Income | $-3.58M |
| Book/sh | $-0.10 |
| Cash/sh | $0.01 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.22 |
Returns & Margins
| ROA | -102.24% |
| Gross Margin | 34.20% |
| Operating Margin | -1762.44% |
Ownership
| Insider Ownership | 36.41% |
| Institutional Ownership | 2.26% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 35.60 |
| P/B | -2.08 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.28 |
| SMA50 | $1.01 |
| RSI | 33.85 |
| ATR | 0.0424 |
| Shares Float | 9.34M |
| Short Float | 2.65% |
| Short Ratio | 0.25 |
| Rel Volume | 0.23 |
Performance History
| Week | -23.05% |
| Month | -38.18% |
| Quarter | -87.94% |
| 6 Months | -93.30% |
| YTD | -93.13% |
| 10 Years | -94.36% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $0.22 | 89,400 |
| 2026-07-16 | $0.22 | 101,700 |
| 2026-07-15 | $0.24 | 408,300 |
| 2026-07-14 | $0.25 | 60,400 |
| 2026-07-13 | $0.25 | 439,300 |
| 2026-07-10 | $0.28 | 189,800 |
| 2026-07-09 | $0.28 | 571,400 |
| 2026-07-08 | $0.29 | 256,000 |
| 2026-07-07 | $0.32 | 916,400 |
| 2026-07-06 | $0.27 | 631,100 |
| 2026-07-02 | $0.29 | 281,600 |
| 2026-07-01 | $0.31 | 683,500 |
| 2026-06-30 | $0.28 | 554,500 |
| 2026-06-29 | $0.28 | 343,000 |
| 2026-06-26 | $0.30 | 908,700 |
| 2026-06-25 | $0.27 | 384,500 |
| 2026-06-24 | $0.29 | 358,400 |
| 2026-06-23 | $0.31 | 227,900 |
| 2026-06-22 | $0.35 | 354,200 |
| 2026-06-18 | $0.32 | 63,900 |
About Phaos Technology Holdings (Caym
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
đ° Latest News
Income Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $101,021 | $828,660 | $414,603 |
| Cost Of Revenue | $101,021 | $828,660 | $414,603 |
| Total Revenue | $129,683 | $1,455,914 | $503,242 |
| Operating Revenue | $129,683 | $1,455,914 | $503,242 |
| Expenses | |||
| Interest Expense | $6,544 | $33,670 | $19,383 |
| Total Expenses | $3,217,837 | $3,301,389 | $1,802,625 |
| Rent Expense Supplemental | $110,322 | $105,769 | $78,979 |
| Other Income Expense | $-882,147 | $54,348 | $29,088 |
| Other Non Operating Income Expenses | $64,032 | $54,348 | $17,662 |
| Net Non Operating Interest Income Expense | $-2,034 | $-33,669 | $-19,381 |
| Interest Expense Non Operating | $6,544 | $33,670 | $19,383 |
| Operating Expense | $3,116,816 | $2,472,730 | $1,388,022 |
| Other Operating Expenses | $325,544 | $126,241 | $-14,496 |
| Selling And Marketing Expense | $44,856 | $67,281 | $26,564 |
| General And Administrative Expense | $2,493,802 | $2,072,530 | $1,203,827 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Net Interest Income | $-2,034 | $-33,669 | $-19,381 |
| Interest Income | $4,510 | $2 | $2 |
| Normalized Income | $-3,026,157 | $-1,824,796 | $-1,301,103 |
| Net Income From Continuing And Discontinued Operation | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Total Operating Income As Reported | $-4,082,774 | $-1,935,594 | $-1,579,185 |
| Net Income Common Stockholders | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Net Income | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Net Income Including Noncontrolling Interests | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Net Income Continuous Operations | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Pretax Income | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Special Income Charges | $-946,179 | $0 | $11,426 |
| Interest Income Non Operating | $4,510 | $2 | $2 |
| Operating Income | $-3,088,154 | $-1,845,475 | $-1,299,384 |
| Depreciation Amortization Depletion Income Statement | $144,573 | $136,647 | $151,283 |
| Depreciation And Amortization In Income Statement | $144,573 | $136,647 | $151,283 |
| Depreciation Income Statement | $144,573 | $136,647 | $151,283 |
| Gross Profit | $28,662 | $627,255 | $88,638 |
| Per Share | |||
| Diluted EPS | - | $-0.14 | $-0.48 |
| Basic EPS | - | $-0.14 | $-0.48 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,875,040 | $-1,654,478 | $-1,130,437 |
| Total Unusual Items | $-946,179 | $0 | $11,426 |
| Total Unusual Items Excluding Goodwill | $-946,179 | $0 | $11,426 |
| Reconciled Depreciation | $144,573 | $136,647 | $151,283 |
| EBITDA (Bullshit earnings) | $-3,821,218 | $-1,654,478 | $-1,119,011 |
| EBIT | $-3,965,791 | $-1,791,125 | $-1,270,294 |
| Diluted NI Availto Com Stockholders | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Tax Provision | $0 | $0 | $0 |
| Gain On Sale Of Ppe | $0 | $0 | $11,426 |
| Write Off | $946,179 | $0 | - |
| Research And Development | $108,041 | $70,032 | $20,844 |
| Selling General And Administration | $2,538,658 | $2,139,810 | $1,230,391 |
| Other Gand A | $479,438 | $534,688 | $88,205 |
| Rent And Landing Fees | $110,322 | $105,769 | $78,979 |
| Salaries And Wages | $1,904,042 | $1,432,073 | $1,036,643 |
| Diluted Average Shares | - | $10,285,839 | $10,285,839 |
| Basic Average Shares | - | $10,285,839 | $10,285,839 |
Balance Sheet (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-1,517,780 | $2,258,105 | $-2,333,073 |
| Total Assets | $1,495,541 | $4,009,068 | $1,068,942 |
| Total Non Current Assets | $323,538 | $349,096 | $365,810 |
| Current Assets | $1,172,002 | $3,659,972 | $703,132 |
| Other Current Assets | $37,310 | $779 | $15,499 |
| Current Deferred Assets | $384,549 | $173,749 | $0 |
| Prepaid Assets | $71,257 | $49,604 | $90,166 |
| Inventory | $239,719 | $145,053 | $117,168 |
| Receivables | $338,989 | $1,502,904 | $438,467 |
| Loans Receivable | $309,308 | $1,183,862 | $0 |
| Accounts Receivable | $29,681 | $319,043 | $423,909 |
| Allowance For Doubtful Accounts Receivable | $0 | $-18,255 | $-16,263 |
| Gross Accounts Receivable | $29,681 | $337,297 | $440,172 |
| Cash Cash Equivalents And Short Term Investments | $100,179 | $1,787,882 | $41,832 |
| Cash And Cash Equivalents | $100,179 | $1,787,882 | $41,832 |
| Other Receivables | - | - | $14,558 |
| Debt | |||
| Net Debt | $3,423 | - | $513,312 |
| Total Debt | $205,554 | $612,878 | $684,617 |
| Long Term Debt And Capital Lease Obligation | $78,154 | $169,608 | $503,927 |
| Long Term Debt | $60,598 | $103,602 | $444,292 |
| Current Debt And Capital Lease Obligation | $127,400 | $443,270 | $180,689 |
| Current Debt | $43,004 | $340,590 | $110,851 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $3,013,320 | $1,750,963 | $3,402,014 |
| Total Non Current Liabilities Net Minority Interest | $78,154 | $169,608 | $503,927 |
| Current Liabilities | $2,935,167 | $1,581,355 | $2,898,087 |
| Payables And Accrued Expenses | $2,783,022 | $1,113,340 | $2,692,653 |
| Payables | $2,706,137 | $1,058,420 | $2,619,059 |
| Other Payable | $317,233 | $244,305 | $114,352 |
| Total Tax Payable | $0 | $20,230 | $4,654 |
| Accounts Payable | $72,634 | $227,270 | $70,440 |
| Equity | |||
| Common Stock Equity | $-1,517,780 | $2,258,105 | $-2,333,073 |
| Total Equity Gross Minority Interest | $-1,517,780 | $2,258,105 | $-2,333,073 |
| Stockholders Equity | $-1,517,780 | $2,258,105 | $-2,333,073 |
| Other Equity Interest | $-28,805 | $-28,805 | - |
| Gains Losses Not Affecting Retained Earnings | $-884 | $0 | $0 |
| Other Equity Adjustments | $-884 | $-28,805 | - |
| Retained Earnings | $-9,408,472 | $-5,436,136 | $-3,611,341 |
| Other | |||
| Ordinary Shares Number | $10,285,839 | - | - |
| Share Issued | $10,285,839 | - | - |
| Tangible Book Value | $-1,517,780 | $2,258,105 | $-2,333,073 |
| Invested Capital | $-1,414,178 | $2,702,297 | $-1,777,929 |
| Working Capital | $-1,763,164 | $2,078,617 | $-2,194,955 |
| Capital Lease Obligations | $101,952 | $168,686 | $129,473 |
| Total Capitalization | $-1,457,182 | $2,361,707 | $-1,888,781 |
| Additional Paid In Capital | $7,917,668 | $7,720,347 | $1,276,216 |
| Capital Stock | $2,713 | $2,699 | $2,052 |
| Common Stock | $2,713 | $2,699 | $2,052 |
| Long Term Capital Lease Obligation | $17,556 | $66,006 | $59,635 |
| Current Capital Lease Obligation | $84,396 | $102,679 | $69,838 |
| Line Of Credit | $43,004 | $340,590 | $110,851 |
| Current Provisions | $24,745 | $24,745 | $24,745 |
| Current Accrued Expenses | $76,885 | $54,920 | $73,594 |
| Dueto Related Parties Current | $2,316,270 | $566,616 | $2,429,613 |
| Net PPE | $323,538 | $349,096 | $365,810 |
| Accumulated Depreciation | $-529,666 | $-409,387 | $-307,747 |
| Gross PPE | $853,205 | $758,483 | $673,557 |
| Construction In Progress | $671 | $0 | - |
| Other Properties | $665,525 | $528,394 | $494,370 |
| Machinery Furniture Equipment | $85,057 | $61,404 | $49,714 |
| Buildings And Improvements | $101,952 | $168,686 | $129,473 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $125,730 | $62,696 | $105,974 |
| Work In Process | $72,990 | $63,816 | $0 |
| Raw Materials | $41,000 | $18,541 | $11,195 |
Cash Flow Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-3,010,793 | $-1,338,363 | $-1,551,306 |
| Operating Activities | |||
| Operating Cash Flow | $-2,825,045 | $-1,244,552 | $-1,383,014 |
| Cash Flow From Continuing Operating Activities | $-2,825,045 | $-1,244,552 | $-1,383,014 |
| Operating Gains Losses | - | - | $-11,426 |
| Investing Activities | |||
| Capital Expenditure | $-185,749 | $-93,812 | $-168,291 |
| Investing Cash Flow | $-257,374 | $-1,277,673 | $-145,288 |
| Cash Flow From Continuing Investing Activities | $-257,374 | $-1,277,673 | $-145,288 |
| Net Other Investing Changes | $-71,625 | $-1,183,862 | - |
| Financing Activities | |||
| Repurchase Of Capital Stock | $-260,847 | $-2,215,707 | $0 |
| Issuance Of Capital Stock | $197,335 | $6,276,785 | $921,737 |
| Financing Cash Flow | $1,395,599 | $4,268,276 | $1,476,881 |
| Cash Flow From Continuing Financing Activities | $1,395,599 | $4,268,276 | $1,476,881 |
| Net Other Financing Charges | $-210,799 | $-173,749 | - |
| Net Common Stock Issuance | $-63,512 | $4,061,078 | $921,737 |
| Common Stock Issuance | $197,335 | $6,276,785 | $921,737 |
| Other | |||
| Repayment Of Debt | $-340,590 | $-110,951 | $-40,274 |
| Issuance Of Debt | $2,010,501 | $491,898 | $595,418 |
| Interest Paid Supplemental Data | $6,544 | $33,670 | $19,383 |
| End Cash Position | $100,179 | $1,787,882 | $41,832 |
| Beginning Cash Position | $1,787,882 | $41,832 | $93,253 |
| Effect Of Exchange Rate Changes | $-884 | $0 | - |
| Changes In Cash | $-1,686,820 | $1,746,050 | $-51,422 |
| Common Stock Payments | $-260,847 | $-2,215,707 | $0 |
| Net Issuance Payments Of Debt | $1,669,910 | $380,947 | $555,143 |
| Net Long Term Debt Issuance | $1,669,910 | $380,947 | $555,143 |
| Long Term Debt Payments | $-340,590 | $-110,951 | $-40,274 |
| Long Term Debt Issuance | $2,010,501 | $491,898 | $595,418 |
| Net PPE Purchase And Sale | $-185,749 | $-93,812 | $-145,288 |
| Purchase Of PPE | $-185,749 | $-93,812 | $-168,291 |
| Change In Working Capital | $-53,783 | $324,738 | $-307,469 |
| Change In Other Current Liabilities | $-110,322 | $-105,769 | $-73,133 |
| Change In Other Current Assets | $-58,184 | $55,282 | $-56,737 |
| Change In Payables And Accrued Expense | $-79,972 | $309,938 | $95,767 |
| Change In Accrued Expense | $74,664 | $153,108 | $121,665 |
| Change In Payable | $-154,636 | $156,830 | $-25,898 |
| Change In Account Payable | $-154,636 | $156,830 | $-25,898 |
| Change In Inventory | $-94,666 | $-27,885 | $90,109 |
| Change In Receivables | $289,361 | $119,425 | $-369,452 |
| Changes In Account Receivables | $289,361 | $104,866 | $-354,894 |
| Other Non Cash Items | $110,322 | $105,769 | $73,133 |
| Asset Impairment Charge | $946,179 | $13,091 | $1,141 |
| Depreciation Amortization Depletion | $144,573 | $136,647 | $151,283 |
| Depreciation And Amortization | $144,573 | $136,647 | $151,283 |
| Depreciation | $144,573 | $136,647 | $151,283 |
| Net Income From Continuing Operations | $-3,972,335 | $-1,824,796 | $-1,289,677 |
| Sale Of PPE | - | $0 | $23,003 |
| Change In Other Working Capital | - | $-26,253 | $5,977 |
| Gain Loss On Sale Of PPE | - | $0 | $-11,426 |